SlideShare ist ein Scribd-Unternehmen logo
1 von 17
[object Object],[object Object],07/24/10 www.actimusbio.com
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],07/24/10 www.actimusbio.com
[object Object],07/24/10 www.actimusbio.com
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],07/24/10 www.actimusbio.com
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],07/24/10 www.actimusbio.com
[object Object],[object Object],[object Object],[object Object],[object Object],07/24/10 www.actimusbio.com
[object Object],[object Object],[object Object],[object Object],[object Object],07/24/10 www.actimusbio.com
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],07/24/10 www.actimusbio.com
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],07/24/10 www.actimusbio.com
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],07/24/10 www.actimusbio.com
[object Object],07/24/10 www.actimusbio.com Document Development & Internal Approvals 2 Working Days Sponsor Review & Approval 2 Working Days IRB Submissions &  Approval 3 Working Days  DCGI Submissions & Approval 28 Working Days Project Initiation  Approved Protocol  35-40 Days
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],07/24/10 www.actimusbio.com
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],07/24/10 www.actimusbio.com
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],07/24/10 www.actimusbio.com
[object Object],07/24/10 www.actimusbio.com Carvedilol Naratriptan Repaglinide Hctz Pantoprazole Valsartan Imatinib Itraconazole Atorvastatin Eszopiclone Propranolol Hydroxy Itraconazole Venlafaxine  Valacyclovir 4-Hydroxy Propranolol Rizatriptan O-Desmethyl Venlafaxine Aciclovir Respiridone Azithromycin Quetapine Tizanidine 9-Hydroxy Respiridone Aprepitent Lansoprazole Escitalopram Lercanidipine Ethambutol Valproic acid Sibutramine Desloratidine Pyrazinamide Metoprolol Desmethyl Sibutramine Cetrizine Ropinirole Aspirin  Didesmethyl Sibutramine Alfuzosin Bupropion Indomethacin Irbesartan Oxcarbazipine Hydroxy bupropion Olanzapine Sildenafil 10-Hydroxy Oxcarbazipine Metformin Lamotrigin Desmethyl Sildenafil Isoniazid Irbersartan Esomeprazole Levitiracetam Mycophenolate Mofetil Riluzole
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],07/24/10 www.actimusbio.com
[object Object],[object Object],07/24/10 www.actimusbio.com

Weitere ähnliche Inhalte

Was ist angesagt?

DayOne Experts - Next generation clinical trials
DayOne Experts - Next generation clinical trialsDayOne Experts - Next generation clinical trials
DayOne Experts - Next generation clinical trialsDayOne
 
FDA's Case for Quality: What, Why, and How? Changing the Regulatory Paradigm
FDA's Case for Quality: What, Why, and How? Changing the Regulatory ParadigmFDA's Case for Quality: What, Why, and How? Changing the Regulatory Paradigm
FDA's Case for Quality: What, Why, and How? Changing the Regulatory ParadigmGreenlight Guru
 
Epworth HealthCare Case Study
Epworth HealthCare Case StudyEpworth HealthCare Case Study
Epworth HealthCare Case StudyOBS
 
FDA's 510(k) Modernization: What if Anything has Changed? Is Changing? Will C...
FDA's 510(k) Modernization: What if Anything has Changed? Is Changing? Will C...FDA's 510(k) Modernization: What if Anything has Changed? Is Changing? Will C...
FDA's 510(k) Modernization: What if Anything has Changed? Is Changing? Will C...Greenlight Guru
 
5 Predictions for the Medical Device Industry in 2018 (and how you can prepare)
5 Predictions for the Medical Device Industry in 2018 (and how you can prepare)5 Predictions for the Medical Device Industry in 2018 (and how you can prepare)
5 Predictions for the Medical Device Industry in 2018 (and how you can prepare)Greenlight Guru
 
New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for...
New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for...New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for...
New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for...NAMSA
 
Pharmacovigilance Training in Oracle Argus Safety Database with Project
Pharmacovigilance Training in Oracle Argus Safety Database with ProjectPharmacovigilance Training in Oracle Argus Safety Database with Project
Pharmacovigilance Training in Oracle Argus Safety Database with ProjectBioMed Informatics
 
TestSafe – the Auckland Regional Clinical Data Repository
TestSafe – the Auckland Regional Clinical Data RepositoryTestSafe – the Auckland Regional Clinical Data Repository
TestSafe – the Auckland Regional Clinical Data RepositoryHealth Informatics New Zealand
 
Research & development services
Research & development services Research & development services
Research & development services DionJusty
 
How to Prepare for the New EU In Vitro Diagnostics Regulations
How to Prepare for the New EU In Vitro Diagnostics RegulationsHow to Prepare for the New EU In Vitro Diagnostics Regulations
How to Prepare for the New EU In Vitro Diagnostics RegulationsGreenlight Guru
 
Posterior Segment Company Showcase - Graybug Vision
Posterior Segment Company Showcase - Graybug VisionPosterior Segment Company Showcase - Graybug Vision
Posterior Segment Company Showcase - Graybug VisionHealthegy
 
OPHTHALMOLOGY INNOVATION SHOWCASE - Ocular Therapeutix
OPHTHALMOLOGY INNOVATION SHOWCASE - Ocular TherapeutixOPHTHALMOLOGY INNOVATION SHOWCASE - Ocular Therapeutix
OPHTHALMOLOGY INNOVATION SHOWCASE - Ocular TherapeutixHealthegy
 
Public Device & Biopharma Ophthalmology Company Showcase - Adverum Biotechnol...
Public Device & Biopharma Ophthalmology Company Showcase - Adverum Biotechnol...Public Device & Biopharma Ophthalmology Company Showcase - Adverum Biotechnol...
Public Device & Biopharma Ophthalmology Company Showcase - Adverum Biotechnol...Healthegy
 
DIY Lessons from Finland: Building Nightscout into PHRs & EHRs
DIY Lessons from Finland: Building Nightscout into PHRs & EHRsDIY Lessons from Finland: Building Nightscout into PHRs & EHRs
DIY Lessons from Finland: Building Nightscout into PHRs & EHRsMikael Rinnetmäki
 
AXIS Clinicals Corporate Presentation
AXIS Clinicals Corporate PresentationAXIS Clinicals Corporate Presentation
AXIS Clinicals Corporate PresentationAxis Clinicals
 
Cell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval SolutionsCell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval SolutionsCovance
 
KCR Data Management
KCR Data Management KCR Data Management
KCR Data Management KCR
 
DSA_Infographic_Final
DSA_Infographic_FinalDSA_Infographic_Final
DSA_Infographic_Finalmarc corbett
 
Idsc Expertise Capabilities Services Short 10 Slides 2013 10-09
Idsc Expertise Capabilities Services Short 10 Slides 2013 10-09Idsc Expertise Capabilities Services Short 10 Slides 2013 10-09
Idsc Expertise Capabilities Services Short 10 Slides 2013 10-09Mark Creswell
 

Was ist angesagt? (20)

DayOne Experts - Next generation clinical trials
DayOne Experts - Next generation clinical trialsDayOne Experts - Next generation clinical trials
DayOne Experts - Next generation clinical trials
 
FDA's Case for Quality: What, Why, and How? Changing the Regulatory Paradigm
FDA's Case for Quality: What, Why, and How? Changing the Regulatory ParadigmFDA's Case for Quality: What, Why, and How? Changing the Regulatory Paradigm
FDA's Case for Quality: What, Why, and How? Changing the Regulatory Paradigm
 
Epworth HealthCare Case Study
Epworth HealthCare Case StudyEpworth HealthCare Case Study
Epworth HealthCare Case Study
 
FDA's 510(k) Modernization: What if Anything has Changed? Is Changing? Will C...
FDA's 510(k) Modernization: What if Anything has Changed? Is Changing? Will C...FDA's 510(k) Modernization: What if Anything has Changed? Is Changing? Will C...
FDA's 510(k) Modernization: What if Anything has Changed? Is Changing? Will C...
 
5 Predictions for the Medical Device Industry in 2018 (and how you can prepare)
5 Predictions for the Medical Device Industry in 2018 (and how you can prepare)5 Predictions for the Medical Device Industry in 2018 (and how you can prepare)
5 Predictions for the Medical Device Industry in 2018 (and how you can prepare)
 
New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for...
New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for...New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for...
New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for...
 
Pharmacovigilance Training in Oracle Argus Safety Database with Project
Pharmacovigilance Training in Oracle Argus Safety Database with ProjectPharmacovigilance Training in Oracle Argus Safety Database with Project
Pharmacovigilance Training in Oracle Argus Safety Database with Project
 
Sharing Knowledge - Lab outsourcing/Managemeent
Sharing Knowledge - Lab outsourcing/ManagemeentSharing Knowledge - Lab outsourcing/Managemeent
Sharing Knowledge - Lab outsourcing/Managemeent
 
TestSafe – the Auckland Regional Clinical Data Repository
TestSafe – the Auckland Regional Clinical Data RepositoryTestSafe – the Auckland Regional Clinical Data Repository
TestSafe – the Auckland Regional Clinical Data Repository
 
Research & development services
Research & development services Research & development services
Research & development services
 
How to Prepare for the New EU In Vitro Diagnostics Regulations
How to Prepare for the New EU In Vitro Diagnostics RegulationsHow to Prepare for the New EU In Vitro Diagnostics Regulations
How to Prepare for the New EU In Vitro Diagnostics Regulations
 
Posterior Segment Company Showcase - Graybug Vision
Posterior Segment Company Showcase - Graybug VisionPosterior Segment Company Showcase - Graybug Vision
Posterior Segment Company Showcase - Graybug Vision
 
OPHTHALMOLOGY INNOVATION SHOWCASE - Ocular Therapeutix
OPHTHALMOLOGY INNOVATION SHOWCASE - Ocular TherapeutixOPHTHALMOLOGY INNOVATION SHOWCASE - Ocular Therapeutix
OPHTHALMOLOGY INNOVATION SHOWCASE - Ocular Therapeutix
 
Public Device & Biopharma Ophthalmology Company Showcase - Adverum Biotechnol...
Public Device & Biopharma Ophthalmology Company Showcase - Adverum Biotechnol...Public Device & Biopharma Ophthalmology Company Showcase - Adverum Biotechnol...
Public Device & Biopharma Ophthalmology Company Showcase - Adverum Biotechnol...
 
DIY Lessons from Finland: Building Nightscout into PHRs & EHRs
DIY Lessons from Finland: Building Nightscout into PHRs & EHRsDIY Lessons from Finland: Building Nightscout into PHRs & EHRs
DIY Lessons from Finland: Building Nightscout into PHRs & EHRs
 
AXIS Clinicals Corporate Presentation
AXIS Clinicals Corporate PresentationAXIS Clinicals Corporate Presentation
AXIS Clinicals Corporate Presentation
 
Cell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval SolutionsCell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval Solutions
 
KCR Data Management
KCR Data Management KCR Data Management
KCR Data Management
 
DSA_Infographic_Final
DSA_Infographic_FinalDSA_Infographic_Final
DSA_Infographic_Final
 
Idsc Expertise Capabilities Services Short 10 Slides 2013 10-09
Idsc Expertise Capabilities Services Short 10 Slides 2013 10-09Idsc Expertise Capabilities Services Short 10 Slides 2013 10-09
Idsc Expertise Capabilities Services Short 10 Slides 2013 10-09
 

Ähnlich wie Actimus Biosciences

Nichols-Scott-Kite-Pharma-2023.pdf
Nichols-Scott-Kite-Pharma-2023.pdfNichols-Scott-Kite-Pharma-2023.pdf
Nichols-Scott-Kite-Pharma-2023.pdfRichardShi22
 
Report out: IoT-based Healthcare Services
Report out: IoT-based Healthcare Services  Report out: IoT-based Healthcare Services
Report out: IoT-based Healthcare Services US-Ignite
 
Clinical Trial Program
Clinical Trial ProgramClinical Trial Program
Clinical Trial ProgramAADYA
 
Clinical Services and Technology
Clinical Services and TechnologyClinical Services and Technology
Clinical Services and Technologyaccenture
 
Program Presentation Advance Program In Clinical Trial, Research & Data Man...
Program Presentation   Advance Program In Clinical Trial, Research & Data Man...Program Presentation   Advance Program In Clinical Trial, Research & Data Man...
Program Presentation Advance Program In Clinical Trial, Research & Data Man...biinoida
 
Program Presentation Advance Program In Clinical Trial, Research & Data Man...
Program Presentation   Advance Program In Clinical Trial, Research & Data Man...Program Presentation   Advance Program In Clinical Trial, Research & Data Man...
Program Presentation Advance Program In Clinical Trial, Research & Data Man...biinoida
 
Kemxtree Presentation
Kemxtree PresentationKemxtree Presentation
Kemxtree Presentationguest44c9cb9c
 
Opportunities and Challenges of Mobile Health, Wearables and Sensors for Pharma
Opportunities and Challenges of Mobile Health, Wearables and Sensors for PharmaOpportunities and Challenges of Mobile Health, Wearables and Sensors for Pharma
Opportunities and Challenges of Mobile Health, Wearables and Sensors for PharmaJohn Reites
 
Artixio_Accelerators & Incubators MedTech.pdf
Artixio_Accelerators & Incubators MedTech.pdfArtixio_Accelerators & Incubators MedTech.pdf
Artixio_Accelerators & Incubators MedTech.pdfArtixioConsulting
 
Biologics Modular Offering Presentation Series D
Biologics Modular Offering Presentation Series DBiologics Modular Offering Presentation Series D
Biologics Modular Offering Presentation Series Djkarras0434
 
Software as a Medical Device (SaMD) Challenges and Opportunities for 2021 and...
Software as a Medical Device (SaMD) Challenges and Opportunities for 2021 and...Software as a Medical Device (SaMD) Challenges and Opportunities for 2021 and...
Software as a Medical Device (SaMD) Challenges and Opportunities for 2021 and...Greenlight Guru
 
Enterprise Clinical Solutions
Enterprise Clinical SolutionsEnterprise Clinical Solutions
Enterprise Clinical SolutionsIndegene
 
Medvantage Tech Overview
Medvantage Tech OverviewMedvantage Tech Overview
Medvantage Tech Overviewezitizer
 

Ähnlich wie Actimus Biosciences (20)

Stability Dosage-Development-Presentation
Stability Dosage-Development-PresentationStability Dosage-Development-Presentation
Stability Dosage-Development-Presentation
 
Nichols-Scott-Kite-Pharma-2023.pdf
Nichols-Scott-Kite-Pharma-2023.pdfNichols-Scott-Kite-Pharma-2023.pdf
Nichols-Scott-Kite-Pharma-2023.pdf
 
cv1
cv1cv1
cv1
 
Report out: IoT-based Healthcare Services
Report out: IoT-based Healthcare Services  Report out: IoT-based Healthcare Services
Report out: IoT-based Healthcare Services
 
In vitro program
In vitro program In vitro program
In vitro program
 
Brochure
BrochureBrochure
Brochure
 
Clinical Trial Program
Clinical Trial ProgramClinical Trial Program
Clinical Trial Program
 
Clinical Services and Technology
Clinical Services and TechnologyClinical Services and Technology
Clinical Services and Technology
 
Program Presentation Advance Program In Clinical Trial, Research & Data Man...
Program Presentation   Advance Program In Clinical Trial, Research & Data Man...Program Presentation   Advance Program In Clinical Trial, Research & Data Man...
Program Presentation Advance Program In Clinical Trial, Research & Data Man...
 
Program Presentation Advance Program In Clinical Trial, Research & Data Man...
Program Presentation   Advance Program In Clinical Trial, Research & Data Man...Program Presentation   Advance Program In Clinical Trial, Research & Data Man...
Program Presentation Advance Program In Clinical Trial, Research & Data Man...
 
Kemxtree Presentation
Kemxtree PresentationKemxtree Presentation
Kemxtree Presentation
 
Opportunities and Challenges of Mobile Health, Wearables and Sensors for Pharma
Opportunities and Challenges of Mobile Health, Wearables and Sensors for PharmaOpportunities and Challenges of Mobile Health, Wearables and Sensors for Pharma
Opportunities and Challenges of Mobile Health, Wearables and Sensors for Pharma
 
Artixio_Accelerators & Incubators MedTech.pdf
Artixio_Accelerators & Incubators MedTech.pdfArtixio_Accelerators & Incubators MedTech.pdf
Artixio_Accelerators & Incubators MedTech.pdf
 
Biologics Modular Offering Presentation Series D
Biologics Modular Offering Presentation Series DBiologics Modular Offering Presentation Series D
Biologics Modular Offering Presentation Series D
 
Software as a Medical Device (SaMD) Challenges and Opportunities for 2021 and...
Software as a Medical Device (SaMD) Challenges and Opportunities for 2021 and...Software as a Medical Device (SaMD) Challenges and Opportunities for 2021 and...
Software as a Medical Device (SaMD) Challenges and Opportunities for 2021 and...
 
FBradt Resume
FBradt ResumeFBradt Resume
FBradt Resume
 
Resume 03-31-2015
Resume 03-31-2015Resume 03-31-2015
Resume 03-31-2015
 
Enterprise Clinical Solutions
Enterprise Clinical SolutionsEnterprise Clinical Solutions
Enterprise Clinical Solutions
 
Medvantage Tech Overview
Medvantage Tech OverviewMedvantage Tech Overview
Medvantage Tech Overview
 
Hcr Part1
Hcr Part1Hcr Part1
Hcr Part1
 

Actimus Biosciences

  • 1.
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.

Hinweis der Redaktion

  1. Actimus Bio Your Partner For Drug Development
  2. Actimus Bio Your Partner For Drug Development
  3. Actimus Bio Your Partner For Drug Development
  4. Actimus Bio Your Partner For Drug Development
  5. Actimus Bio Your Partner For Drug Development
  6. Actimus Bio Your Partner For Drug Development
  7. Actimus Bio Your Partner For Drug Development
  8. Actimus Bio Your Partner For Drug Development
  9. Actimus Bio Your Partner For Drug Development
  10. Actimus Bio Your Partner For Drug Development
  11. Actimus Bio Your Partner For Drug Development
  12. Actimus Bio Your Partner For Drug Development
  13. Actimus Bio Your Partner For Drug Development
  14. Actimus Bio Your Partner For Drug Development
  15. Actimus Bio Your Partner For Drug Development
  16. Actimus Bio Your Partner For Drug Development
  17. Actimus Bio Your Partner For Drug Development